CIK 0001645460 · Non-accelerated filer<br>Smaller reporting company
Cue Biopharma, Inc.
Sign in to watch- Ticker
- CUE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473324577
- Phone
- 617-949-2680
- Business address
- 100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
- Former names
- Imagen Biopharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $389,304
- in 3 filings
Net −$389,304. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 20 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-30 | Sarraf Pasha Director | Purchase | +4,229 | $0.31 | $1K | 4,229 |
| 2025-12-30 | Sarraf Pasha Director | Purchase | +77,148 | $0.30 | $23K | 81,377 |
| 2025-12-30 | Sarraf Pasha Director | Purchase | +86,947 | $0.32 | $28K | 168,324 |
| 2025-12-30 | Sarraf Pasha Director | Purchase | +78,116 | $0.31 | $24K | 246,440 |
| 2025-12-30 | Sarraf Pasha Director | Purchase | +77,417 | $0.30 | $23K | 323,857 |
| 2024-12-16 | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | Purchase | +30,000 | $1.03 | $31K | 164,578 |
| 2023-08-25 | Suri Anish PRESIDENT AND CSO | Purchase | +4,000 | $2.76 | $11K | 135,638 |
| 2023-08-14 | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | Purchase | +3,000 | $2.86 | $9K | 134,578 |
| 2022-05-27 | Morich Frank Director | Purchase | +28,000 | $3.75 | $105K | 28,000 |
| 2022-05-24 | Fletcher Aaron G.L. Director | Purchase | +55,000 | $3.34 | $184K | 940,000 |
| 2022-05-23 | Fletcher Aaron G.L. Director | Purchase | +150,000 | $3.52 | $528K | 885,000 |
| 2022-03-31 | Fletcher Aaron G.L. Director | Purchase | +735,000 | $4.76 | $3.5M | 735,000 |
| 2021-09-24 | PASSERI DANIEL R CHIEF EXECUTIVE OFFICER | Purchase | +3,400 | $14.72 | $50K | 55,377 |
| 2021-01-20 | Pienta Kenneth Chief Medical Officer | Purchase | +2,720 | $15.07 | $41K | 4,720 |
| 2020-11-24 | Fletcher Aaron G.L. Director | Purchase | +6,548 | $12.64 | $83K | 165,000 |
| 2020-09-30 | Gray Cameron Director | Purchase | +5,000 | $15.30 | $77K | 677,500 |
| 2020-09-29 | Gray Cameron Director | Purchase | +5,000 | $15.00 | $75K | 672,500 |
| 2020-06-24 | Fletcher Aaron G.L. Director | Purchase | +4,547 | $24.64 | $112K | 155,499 |
| 2020-06-24 | Fletcher Aaron G.L. Director | Purchase | +2,953 | $25.24 | $75K | 158,452 |
| 2019-06-21 | PASSERI DANIEL R CEO and President | Purchase | +1,377 | $7.26 | $10K | 51,977 |
Page 1 of 3 · 41 trades